2022 ICD-10-CM Code C7A.098
Malignant carcinoid tumors of other sites
Code Classification
C7A.098 is a billable diagnosis code used to specify a medical diagnosis of malignant carcinoid tumors of other sites. The code C7A.098 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code C7A.098 might also be used to specify conditions or terms like carcinoid tumor of pancreas, malignant carcinoid tumor of pancreas or malignant tumor of endocrine pancreas.
Entries in the Index to Diseases and Injuries with references to C7A.098
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C7A.098 are found in the index:
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Carcinoid tumor of pancreas
- Malignant carcinoid tumor of pancreas
- Malignant tumor of endocrine pancreas
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code C7A.098 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
| MS-DRG | MS-DRG Title | MCD | Relative Weight |
|---|---|---|---|
| 826 | MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC | 17 | 5.0368 |
| 827 | MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC | 17 | 2.4976 |
| 828 | MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC | 17 | 1.6777 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert C7A.098 to ICD-9 Code
- 209.29 - Malig carcinoid oth site
Information for Patients
Carcinoid Tumors
Carcinoid tumors are rare, slow-growing cancers. They usually start in the lining of the digestive tract or in the lungs. They grow slowly and don't produce symptoms in the early stages. As a result, the average age of people diagnosed with digestive or lung carcinoids is about 60.
In later stages the tumors sometimes produce hormones that can cause carcinoid syndrome. The syndrome causes flushing of the face and upper chest, diarrhea, and trouble breathing.
Surgery is the main treatment for carcinoid tumors. If they haven't spread to other parts of the body, surgery can cure the cancer.
[Learn More in MedlinePlus]
Related Codes
| ICD Code | Description | Valid for Submission |
|---|---|---|
| C7A | Malignant neuroendocrine tumors | NON-BILLABLE CODE |
| C7A.0 | Malignant carcinoid tumors | NON-BILLABLE CODE |
| C7A.00 | Malignant carcinoid tumor of unspecified site | BILLABLE CODE |
| C7A.01 | Malignant carcinoid tumors of the small intestine | NON-BILLABLE CODE |
| C7A.010 | Malignant carcinoid tumor of the duodenum | BILLABLE CODE |
| C7A.011 | Malignant carcinoid tumor of the jejunum | BILLABLE CODE |
| C7A.012 | Malignant carcinoid tumor of the ileum | BILLABLE CODE |
| C7A.019 | Malignant carcinoid tumor of the small intestine, unspecified portion | BILLABLE CODE |
| C7A.02 | Malignant carcinoid tumors of the appendix, large intestine, and rectum | NON-BILLABLE CODE |
| C7A.020 | Malignant carcinoid tumor of the appendix | BILLABLE CODE |
| C7A.021 | Malignant carcinoid tumor of the cecum | BILLABLE CODE |
| C7A.022 | Malignant carcinoid tumor of the ascending colon | BILLABLE CODE |
| C7A.023 | Malignant carcinoid tumor of the transverse colon | BILLABLE CODE |
| C7A.024 | Malignant carcinoid tumor of the descending colon | BILLABLE CODE |
| C7A.025 | Malignant carcinoid tumor of the sigmoid colon | BILLABLE CODE |
| C7A.026 | Malignant carcinoid tumor of the rectum | BILLABLE CODE |
| C7A.029 | Malignant carcinoid tumor of the large intestine, unspecified portion | BILLABLE CODE |
| C7A.09 | Malignant carcinoid tumors of other sites | NON-BILLABLE CODE |
| C7A.090 | Malignant carcinoid tumor of the bronchus and lung | BILLABLE CODE |
| C7A.091 | Malignant carcinoid tumor of the thymus | BILLABLE CODE |
| C7A.092 | Malignant carcinoid tumor of the stomach | BILLABLE CODE |
| C7A.093 | Malignant carcinoid tumor of the kidney | BILLABLE CODE |
| C7A.094 | Malignant carcinoid tumor of the foregut, unspecified | BILLABLE CODE |
| C7A.095 | Malignant carcinoid tumor of the midgut, unspecified | BILLABLE CODE |
| C7A.096 | Malignant carcinoid tumor of the hindgut, unspecified | BILLABLE CODE |
| C7A.1 | Malignant poorly differentiated neuroendocrine tumors | BILLABLE CODE |
| C7A.8 | Other malignant neuroendocrine tumors | BILLABLE CODE |
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)
